Diabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University ...
Feb 22, 2024
0
9
Immune checkpoint inhibitors are widely used to treat a variety of cancers; however, one serious side effect is the onset of type 1 diabetes. Now, researchers from Osaka University have discovered that stem cell therapy may ...
May 5, 2022
0
139
A clinical trial initiated by University of Kentucky researchers argues against the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass. The double-blind trial, conducted at the ...
Oct 22, 2019
0
89
A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to immunotherapies. Led by Ping-Chih Ho of the Lausanne Branch of the ...
Jan 23, 2019
0
2
The world's most commonly used Type 2 diabetes drug, Metformin, may be 'repurposed' to treat non-diabetic conditions according to researchers from the University of Dundee.
Aug 22, 2016
0
5
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, finds a study published by The BMJ today. The findings suggest that the risk increases with increasing duration of use and dose.
Mar 31, 2016
0
131
"What if you could cure all your health problems and lose 10 pounds in just 7 days? That's an amazing claim, hard to believe for sure, but I have seen this miracle so many times in my practice that even I am starting to believe ...
Mar 22, 2016
0
46
A blood thinner known for serious drug interactions is linked to increased hospitalizations for falls, altered mental state and insulin shock for Medicare patients who also take some diabetes drugs, according to a new study.
Dec 7, 2015
0
44
There is strong evidence that inflammation promotes obesity-associated type 2 diabetes and diabetes complications. However, clinical trials with anti-inflammatory drugs have only been modestly effective for treating Type ...
Nov 19, 2015
0
17
In the first study of its kind, Penn researchers have shown how an anti-diabetic drug can have variable effects depending on small natural differences in DNA sequence between individuals. Mitchell Lazar, MD, PhD, Raymond ...
Jul 2, 2015
0
20
